Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines

Sandro C Esteves; Alessandro Conforti; Sesh K Sunkara; Luigi Carbone; Silvia Picarelli; Alberto Vaiarelli; Danilo Cimadomo; Laura Rienzi; Filippo Maria Ubaldi; Fulvio Zullo; Claus Yding Andersen; Raoul Orvieto; Peter Humaidan; Carlo Alviggi

doi:10.3389/fendo.2021.587051

Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines

Sandro C Esteves, Alessandro Conforti, Sesh K Sunkara, Luigi Carbone, Silvia Picarelli, Alberto Vaiarelli, Danilo Cimadomo, Laura Rienzi, Filippo Maria Ubaldi, Fulvio Zullo, Claus Yding Andersen, Raoul Orvieto, Peter Humaidan, Carlo Alviggi

Abstract

The POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) criteria were developed to help clinicians identify and classify low-prognosis patients undergoing assisted reproductive technology (ART) and provide guidance for possible therapeutic strategies to overcome infertility. Since its introduction, the number of published studies using the POSEIDON criteria has increased steadily. However, a critical analysis of existing evidence indicates inconsistent and incomplete reporting of critical outcomes. Therefore, we developed guidelines to help researchers improve the quality of reporting in studies applying the POSEIDON criteria. We also discuss the advantages of using the POSEIDON criteria in ART clinical studies and elaborate on possible study designs and critical endpoints. Our ultimate goal is to advance the knowledge concerning the clinical use of the POSEIDON criteria to patients, clinicians, and the infertility community.

Originalsprog	Engelsk
Artikelnummer	587051
Tidsskrift	Frontiers in Endocrinology
Vol/bind	12
Sider (fra-til)	587051
ISSN	1664-2392
DOI	https://doi.org/10.3389/fendo.2021.587051
Status	Udgivet - 19 mar. 2021

Adgang til dokumentet

10.3389/fendo.2021.587051

Andre filer og links

Link to publication in Scopus

Citationsformater

Esteves, S. C., Conforti, A., Sunkara, S. K., Carbone, L., Picarelli, S., Vaiarelli, A., Cimadomo, D., Rienzi, L., Ubaldi, F. M., Zullo, F., Andersen, C. Y., Orvieto, R., Humaidan, P., & Alviggi, C. (2021). Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines. Frontiers in Endocrinology, 12, 587051. Artikel 587051. https://doi.org/10.3389/fendo.2021.587051

@article{c8743a8df0104a85ab4454115e809a9f,

title = "Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines",

abstract = "The POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) criteria were developed to help clinicians identify and classify low-prognosis patients undergoing assisted reproductive technology (ART) and provide guidance for possible therapeutic strategies to overcome infertility. Since its introduction, the number of published studies using the POSEIDON criteria has increased steadily. However, a critical analysis of existing evidence indicates inconsistent and incomplete reporting of critical outcomes. Therefore, we developed guidelines to help researchers improve the quality of reporting in studies applying the POSEIDON criteria. We also discuss the advantages of using the POSEIDON criteria in ART clinical studies and elaborate on possible study designs and critical endpoints. Our ultimate goal is to advance the knowledge concerning the clinical use of the POSEIDON criteria to patients, clinicians, and the infertility community.",

keywords = "Adult, Female, Humans, Infertility, Female/diagnosis, Oocytes/pathology, Ovarian Reserve/physiology, Patient-Centered Care/methods, Practice Guidelines as Topic/standards, Precision Medicine/methods, Pregnancy, Prognosis, Public Reporting of Healthcare Data, Quality Improvement/standards, Reproductive Techniques, Assisted/standards",

author = "Esteves, {Sandro C} and Alessandro Conforti and Sunkara, {Sesh K} and Luigi Carbone and Silvia Picarelli and Alberto Vaiarelli and Danilo Cimadomo and Laura Rienzi and Ubaldi, {Filippo Maria} and Fulvio Zullo and Andersen, {Claus Yding} and Raoul Orvieto and Peter Humaidan and Carlo Alviggi",

note = "Copyright {\textcopyright} 2021 Esteves, Conforti, Sunkara, Carbone, Picarelli, Vaiarelli, Cimadomo, Rienzi, Ubaldi, Zullo, Andersen, Orvieto, Humaidan and Alviggi.",

year = "2021",

month = mar,

day = "19",

doi = "10.3389/fendo.2021.587051",

language = "English",

volume = "12",

pages = "587051",

journal = "Frontiers in Endocrinology",

issn = "1664-2392",

publisher = "Frontiers Research Foundation",

}

TY - JOUR

T1 - Improving Reporting of Clinical Studies Using the POSEIDON Criteria

T2 - POSORT Guidelines

AU - Esteves, Sandro C

AU - Conforti, Alessandro

AU - Sunkara, Sesh K

AU - Carbone, Luigi

AU - Picarelli, Silvia

AU - Vaiarelli, Alberto

AU - Cimadomo, Danilo

AU - Rienzi, Laura

AU - Ubaldi, Filippo Maria

AU - Zullo, Fulvio

AU - Andersen, Claus Yding

AU - Orvieto, Raoul

AU - Humaidan, Peter

AU - Alviggi, Carlo

PY - 2021/3/19

Y1 - 2021/3/19

N2 - The POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) criteria were developed to help clinicians identify and classify low-prognosis patients undergoing assisted reproductive technology (ART) and provide guidance for possible therapeutic strategies to overcome infertility. Since its introduction, the number of published studies using the POSEIDON criteria has increased steadily. However, a critical analysis of existing evidence indicates inconsistent and incomplete reporting of critical outcomes. Therefore, we developed guidelines to help researchers improve the quality of reporting in studies applying the POSEIDON criteria. We also discuss the advantages of using the POSEIDON criteria in ART clinical studies and elaborate on possible study designs and critical endpoints. Our ultimate goal is to advance the knowledge concerning the clinical use of the POSEIDON criteria to patients, clinicians, and the infertility community.

AB - The POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) criteria were developed to help clinicians identify and classify low-prognosis patients undergoing assisted reproductive technology (ART) and provide guidance for possible therapeutic strategies to overcome infertility. Since its introduction, the number of published studies using the POSEIDON criteria has increased steadily. However, a critical analysis of existing evidence indicates inconsistent and incomplete reporting of critical outcomes. Therefore, we developed guidelines to help researchers improve the quality of reporting in studies applying the POSEIDON criteria. We also discuss the advantages of using the POSEIDON criteria in ART clinical studies and elaborate on possible study designs and critical endpoints. Our ultimate goal is to advance the knowledge concerning the clinical use of the POSEIDON criteria to patients, clinicians, and the infertility community.

KW - Adult

KW - Female

KW - Humans

KW - Infertility, Female/diagnosis

KW - Oocytes/pathology

KW - Ovarian Reserve/physiology

KW - Patient-Centered Care/methods

KW - Practice Guidelines as Topic/standards

KW - Precision Medicine/methods

KW - Pregnancy

KW - Prognosis

KW - Public Reporting of Healthcare Data

KW - Quality Improvement/standards

KW - Reproductive Techniques, Assisted/standards

UR - http://www.scopus.com/inward/record.url?scp=85103563710&partnerID=8YFLogxK

U2 - 10.3389/fendo.2021.587051

DO - 10.3389/fendo.2021.587051

M3 - Journal article

C2 - 33815269

SN - 1664-2392

VL - 12

SP - 587051

JO - Frontiers in Endocrinology

JF - Frontiers in Endocrinology

M1 - 587051

ER -

Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater